Point72 Hong Kong’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,022
Closed -$213K – 1776
2022
Q3
$213K Buy
3,022
+2,131
+239% +$147K 0.01% 1033
2022
Q2
$50K Buy
+891
New +$48.8K ﹤0.01% 1375
2021
Q4
– Sell
-2,394
Closed -$156K – 2497
2021
Q3
$156K Sell
2,394
-1,862
-44% -$127K 0.01% 1239
2021
Q2
$270K Buy
4,256
+3,968
+1,378% +$234K 0.01% 1079
2021
Q1
$17K Buy
+288
New +$15.7K ﹤0.01% 1512
2020
Q4
– Sell
-1,362
Closed -$70K – 2102
2020
Q3
$70K Buy
+1,362
New +$56.9K 0.01% 621
2020
Q2
– Sell
-260
Closed -$7K – 1482
2020
Q1
$7K Sell
260
-759
-74% -$22.6K ﹤0.01% 744
2019
Q4
$28K Buy
+1,019
New +$24.3K 0.01% 821
2019
Q1
– Sell
-157
Closed -$2K – 1334
2018
Q4
$2K Buy
+157
New +$2.34K ﹤0.01% 762

Other funds holding AXNX

Point72 Hong Kong's AXNX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 3,022 shares — an estimated $213K sold.

Point72 Hong Kong first reported a position in AXNX in Q4 2018 and held it in 9 quarters. The position peaked at $270K in Q2 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

  • Point72 Hong Kong reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 3,022 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $213K.
  • Point72 Hong Kong first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 9 quarters.
  • Point72 Hong Kong's Axonics, Inc. Common Stock position peaked at $270K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.